Houston has one of the largest healthcare M&A markets in the US, driven by hospital systems, physician groups, and pharma. This covers 11 advisors in Houston that specialize in healthcare M&A in 2026.
Healthcare M&A in Houston in 2026
Houston is home to the Texas Medical Center, the world's largest medical complex. That concentration of hospitals, research institutions, and life sciences companies generates consistent M&A activity.
Healthcare M&A in Houston spans hospital system consolidation, physician practice roll-ups, pharma licensing, medtech acquisitions, and home health platform deals. Each sub-sector uses different advisors and different buyer pools.
Prepare your due diligence materials early - healthcare buyers add regulatory, compliance, and payer contract reviews to standard financial diligence. The process is longer than in most other sectors.
If your business serves the healthcare sector but operates in industrials or services, see our Houston industrials M&A guide as well. Some advisors cross both sectors.
| Advisor | Deal Type | Deal Size | Sector Focus | Website | |
|---|---|---|---|---|---|
| Houlihan Lokey | Houlihan Lokey | Both | $25M-$5B+ | Healthcare, industrials, TMT, energy | hl.com |
| Leerink Partners | Leerink Partners | Both | $50M-$5B+ | Biopharma, medtech, diagnostics, healthcare services | leerink.com |
| TD Cowen | TD Cowen | Both | $50M-$5B+ | Biopharma, medtech, genomics, healthcare IT | cowen.com |
| Raymond James | Raymond James | Both | $25M-$500M | Healthcare services, pharma, medtech, consumer | raymondjames.com |
| Harris Williams | Harris Williams | Both | $50M-$1B+ | Healthcare services, business services, industrials | harriswilliams.com |
| Piper Sandler | Piper Sandler | Both | $25M-$2B+ | Healthcare services, biopharma, medtech, behavioral health | pipersandler.com |
| Cain Brothers (RBC) | Cain Brothers (RBC) | Both | $25M-$2B+ | Hospitals, senior living, behavioral health, physician groups | cainbrothers.com |
| GulfStar Group | GulfStar Group | Both | $10M-$350M | Healthcare services, energy, industrials, consumer | gulfstargroup.com |
| Moelis | Moelis | Both | $200M+ | Healthcare, pharma, medtech, consumer, TMT | moelis.com |
| Lincoln International | Lincoln International | Both | $25M-$500M | Healthcare services, industrials, business services | lincolninternational.com |
| Lazard | Lazard | Both | $200M+ | Healthcare, pharma, biotech, medical devices | lazard.com |
What healthcare M&A buyers check first
Payer contract mix — commercial, Medicare, Medicaid — is reviewed in the first round of healthcare diligence. Revenue concentration in government payers at high rates draws buyer scrutiny.
Regulatory status, accreditation, and licensing are checked before LOI in most healthcare deals. Buyers will not proceed if there are pending citations, corrective action plans, or unresolved audits.
Physician alignment and retention are underwritten in physician group and hospital deals. Key physician departure risk post-close is the most common value-reduction factor in healthcare M&A.
Clinical quality metrics and outcomes data are reviewed by healthcare strategics and PE groups. A strong quality record supports premium pricing and reduces diligence risk for the buyer. See our financial due diligence guide for what sellers should prepare before diligence begins.
Types of Houston healthcare M&A deals
Hospital and health system consolidation remains the largest category by deal value in Houston in 2026. The Texas Medical Center's density drives hospital-to-hospital transactions and system acquisitions.
Physician practice management (PPM) continues to attract PE capital in Houston. Dermatology, orthopedics, ophthalmology, and multi-specialty groups are the most active sub-sectors.
Pharma and biotech licensing, co-development deals, and asset acquisitions are handled by specialized advisors like Leerink and TD Cowen. These require scientific and clinical expertise alongside financial analysis.
Home health, behavioral health, and ambulatory surgery center deals have grown rapidly since 2023. These sub-sectors attract both strategic buyers and infrastructure PE firms at premium multiples.
Selling a Houston healthcare business?
Organize payer contracts, clinical data, and financials in one secure Ellty room.
Start free 14-day trial11 Houston healthcare M&A advisors
These firms are active in healthcare M&A in Houston in 2026. Coverage ranges from hospital systems and physician groups to pharma, medtech, and behavioral health.
1. Houlihan Lokey
Houlihan Lokey is the largest independent investment bank globally by M&A deal count with a dedicated healthcare group covering services, devices, and pharma.
Recent Deals: Ranked #1 M&A advisor globally by deal count in H1 2025. Active in healthcare services, medtech, and pharma M&A through 2025-2026 with dedicated Houston healthcare coverage and global buy-side relationships.
LinkedIn: Houlihan Lokey on LinkedIn
Sector Focus: Healthcare, industrials, TMT, energy
Deal Type: Both
Deal Size: $25M-$5B+
Location: Houston, TX (national coverage)
Website: hl.com
2. Leerink Partners
Leerink Partners is a pure-play healthcare boutique focused exclusively on biopharma, medtech, and diagnostics M&A and capital markets.
Recent Deals: Active in biopharma M&A and capital raises through 2025-2026, advising on licensing transactions, asset acquisitions, and strategic combinations across the biotech and life sciences sectors with deep institutional investor relationships.
LinkedIn: Leerink Partners on LinkedIn
Sector Focus: Biopharma, medtech, diagnostics, healthcare services
Deal Type: Both
Deal Size: $50M-$5B+
Location: New York, NY (national healthcare coverage including Houston)
Website: leerink.com
3. TD Cowen
TD Cowen's healthcare group covers biopharma, medtech, genomics, and healthcare IT M&A with institutional research and banking combined.
Recent Deals: Active in biopharma and medtech M&A and capital markets through 2025-2026. TD Cowen's healthcare platform combines equity research, investment banking, and prime brokerage for a complete healthcare capital markets offering.
LinkedIn: TD Cowen on LinkedIn
Sector Focus: Biopharma, medtech, genomics, healthcare IT
Deal Type: Both
Deal Size: $50M-$5B+
Location: New York, NY and national coverage (including Houston)
Website: cowen.com
4. Raymond James
Raymond James runs healthcare M&A from Houston with a mid-market focus across services, pharma, and devices.
Recent Deals: Active in healthcare services, pharma, and medtech M&A through 2025-2026. Raymond James operates one of the largest middle-market investment banking platforms in the US with dedicated healthcare sector coverage.
LinkedIn: Raymond James on LinkedIn
Sector Focus: Healthcare services, pharma, medtech, consumer
Deal Type: Both
Deal Size: $25M-$500M
Location: Houston, TX and national coverage
Website: raymondjames.com
5. Harris Williams
Harris Williams is a mid-market M&A boutique with a strong healthcare services practice covering physician groups, home health, and behavioral health.
Recent Deals: Consistently active in healthcare services and business services M&A through 2025-2026. Harris Williams is particularly strong in sell-side processes for multi-site healthcare service platforms where PE roll-up buyers are the primary audience.
LinkedIn: Harris Williams on LinkedIn
Sector Focus: Healthcare services, business services, industrials
Deal Type: Both (primarily sell-side)
Deal Size: $50M-$1B+
Location: Richmond, VA (national coverage including Houston)
Website: harriswilliams.com
6. Piper Sandler
Piper Sandler's healthcare group is one of the most active in the US for mid-market healthcare services and behavioral health M&A.
Recent Deals: Named 2025 Outstanding M&A Investment Bank of the Year by the Global M&A Network. Active in healthcare services, biopharma, and behavioral health M&A through 2025-2026 with dedicated sector teams.
LinkedIn: Piper Sandler on LinkedIn
Sector Focus: Healthcare services, biopharma, medtech, behavioral health
Deal Type: Both
Deal Size: $25M-$2B+
Location: Houston, TX and national coverage
Website: pipersandler.com
Healthcare deal in Houston?
Set permissions by buyer type and track engagement with your clinical and financial data.
Start free 14-day trial7. Cain Brothers (RBC)
Cain Brothers is the most specialized healthcare boutique for hospital systems, senior living, and behavioral health transactions in the US.
Recent Deals: Active in hospital system M&A, senior living, and behavioral health through 2025-2026 as the dedicated healthcare advisory arm of RBC Capital Markets. Cain Brothers is the go-to boutique for mission-driven healthcare organizations and non-profit system deals.
LinkedIn: RBC Capital Markets on LinkedIn
Sector Focus: Hospitals, senior living, behavioral health, physician groups
Deal Type: Both
Deal Size: $25M-$2B+
Location: Houston, TX and national coverage
Website: cainbrothers.com
8. GulfStar Group
GulfStar covers healthcare services alongside energy, industrials, and consumer from its Houston headquarters.
Recent Deals: Won ACG Houston Impact Deal of Year at ACG Houston April 2026. Active in Houston healthcare services M&A through 2025-2026 alongside energy, industrials, and consumer coverage from its Houston-based team.
LinkedIn: GulfStar Group on LinkedIn
Sector Focus: Healthcare services, energy, industrials, consumer
Deal Type: Both
Deal Size: $10M-$350M
Location: Houston, TX
Website: gulfstargroup.com
9. Moelis
Moelis is an independent investment bank active in large-cap healthcare, pharma, and medtech M&A with dedicated Houston market coverage.
Recent Deals: Active in large-cap healthcare, pharma, and consumer M&A through 2025-2026. Moelis is known for advising on complex healthcare transactions including pharma licensing deals, divestitures, and spin-offs at the large-cap and mid-cap level.
LinkedIn: Moelis on LinkedIn
Sector Focus: Healthcare, pharma, medtech, consumer, TMT
Deal Type: Both
Deal Size: $200M+
Location: Houston, TX and New York, NY
Website: moelis.com
10. Lincoln International
Lincoln International covers healthcare services M&A in the mid-market alongside its strong industrials and business services practices.
Recent Deals: Active in healthcare services and business services M&A through 2025-2026 with global reach for cross-border healthcare deals. Lincoln's Houston team covers mid-market healthcare platforms and services businesses alongside the broader North American coverage.
LinkedIn: Lincoln International on LinkedIn
Sector Focus: Healthcare services, industrials, business services
Deal Type: Both
Deal Size: $25M-$500M
Location: Houston, TX and global coverage
Website: lincolninternational.com
11. Lazard
Lazard advises on large-cap pharma, biotech, and medical device M&A with dedicated healthcare coverage and global reach from Houston.
Recent Deals: Active in large-cap healthcare, pharma, biotech, and medical device M&A through 2025-2026. Lazard's healthcare team works alongside its energy practice from Houston to cover diversified healthcare and life sciences mandates.
LinkedIn: Lazard on LinkedIn
Sector Focus: Healthcare, pharma, biotech, medical devices
Deal Type: Both
Deal Size: $200M+
Location: Houston, TX and New York, NY
Website: lazard.com
How to value a healthcare business
Healthcare services businesses are primarily valued on EBITDA multiples adjusted for payer mix, physician alignment, and regulatory risk. Quality platforms with commercial payer concentration trade at 12-18x EBITDA in 2026.
Pharma and biotech assets are valued on discounted cash flow, pipeline probability, and comparable transaction analysis. Assets with Phase 2 or Phase 3 clinical data command the highest premiums.
Medtech devices are valued on revenue multiples where SaaS-like recurring revenue streams exist. Capital equipment with high consumable attachment rates and service contracts trade at premium valuations.
Use Ellty for lead capture to track which buyers engage with your financial summary before your advisor launches the full process. Early buyer engagement signals help you prioritize outreach.
Healthcare data room requirements
Healthcare M&A data rooms require more documents than general M&A processes. Payer contracts, licensure files, accreditation certificates, and compliance documentation are all standard inclusions.
Organize your data room by category: financial, legal and regulatory, clinical operations, HR and compensation, and real estate. Buyers' advisors follow this structure and will note disorganized rooms in their reports.
Set access controls so clinical data and patient-related documents are only accessible to credentialed buyers after NDA. Use Ellty's security features to restrict document printing and downloading on sensitive files.
A quality of earnings report from an independent accounting firm dramatically reduces diligence time. Commission one before marketing starts to pre-empt buyer adjustments to your EBITDA presentation.
How to choose a healthcare M&A firm
Match the advisor to your healthcare sub-sector precisely. Cain Brothers for hospital systems, Leerink or TD Cowen for pharma and biotech, and Harris Williams or Piper Sandler for healthcare services.
Size the mandate to the right tier. Boutiques run better processes for sub-$500M deals where relationship quality and buyer access matter more than balance sheet capacity.
Ask advisors to name their last three closed deals in your sub-sector with buyer identities. Any firm that cannot do this is not your advisor for healthcare.
See how healthcare M&A advisors approach similar markets via the Chicago M&A advisor guide. Chicago has a large physician group and hospital M&A market that runs similarly to Houston. Compare Dallas M&A advisor activity as well since many Houston healthcare buyers are also active in Dallas.
How Ellty helps you run a healthcare M&A process in Houston
You have your healthcare advisor shortlist. Here is how to prepare your documents before buyer outreach begins.
- 1.Upload financials, payer contracts, and accreditation filesAdd three years of financials and payer contract summaries before advisors contact buyers. Include licensure and accreditation certificates so buyers can confirm compliance status early.
- 2.Set permissions by buyer tier and deal stageShare revenue summary and payer mix before NDA. Open full financials and physician contracts after NDA. Unlock HR, real estate, and clinical quality files after LOI is signed.
- 3.Track which buyers engage with your key documentsSee which buyers open your payer contract summaries and how long they read your quality of earnings report. Activity data helps you follow up with the most engaged buyers first.
Common questions about Houston healthcare M&A advisors
- Cain Brothers for hospital systems and senior living, Leerink Partners and TD Cowen for pharma and medtech, and Harris Williams and Piper Sandler for healthcare services platforms.
- Quality healthcare services businesses with commercial payer concentration trade at 12-18x EBITDA in 2026. Lower multiples apply for Medicaid-heavy revenue mixes or businesses with key-person risk.
- Most mid-market healthcare deals run seven to ten months from advisor engagement to close. Regulatory approvals, accreditation transfer, and payer credentialing reviews add time versus non-healthcare sectors.
- Yes - in healthcare M&A, buyers expect a QoE from an independent firm before LOI. Commissioning one before marketing starts signals seller credibility and reduces diligence surprises.
- Physician retention risk is the most common deal-breaker. Key physician departures after close can trigger earn-out disputes and value reduction. Buyers price this risk aggressively in offers.
